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Within the last 25 years, bacteriophage integrases have rapidly risen to prominence as genetic tools for a wide
range of applications from basic cloning to genome engineering. Serine integrases such as that from ϕC31
and its relatives have found an especially wide range of applications within diverse micro-organisms right
through to multi-cellular eukaryotes. Here, we review the mechanisms of the two major families of integrases,
the tyrosine and serine integrases, and the advantages and disadvantages of each type as they are applied in
genome engineering and synthetic biology. In particular, we focus on the new areas of metabolic pathway
construction and optimization, biocomputing, heterologous expression and multiplexed assembly techniques.
Integrases are versatile and efficient tools that can be used in conjunction with the various extant molecular
biology tools to streamline the synthetic biology production line.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).Introduction
Bacteriophages
Viruses are themost abundant biological entities on
this planet, with an estimated 1030 present in the
oceans alone [1]. The vast majority of viruses are
bacteriophages (viruses that infect bacteria) and
these outnumber bacteria by about 10 to 1 [2].
Bacteriophage lytic activity significantly affects bacte-
rial mortality and nutrient cycling whereas non-lytic
interactions between bacteriophage and host can
lead to the distribution of traits beneficial to their hosts,
such as antibiotic and phage resistance or increased
virulence. Upon infection of a new host, most
bacteriophages proceed through the lytic lifecycle,
where they subvert the host molecular machinery for
the sole purpose of rapid self-replication and dissem-
ination. However, under certain conditions, temperate
phages are also able to integrate their own genome
into that of the host and remain essentially quiescentAuthors. Published by Elsevier Ltd. T
rg/licenses/by/3.0/).for an indeterminate time, until stimulated to return to
lytic replication [3]. This process of phage genome
integration is mediated by phage-encoded inte-
grases that, in the absence of any other phage-en-
coded factors, catalyse unidirectional and highly
site-specific recombination reactions (Fig. 1). Upon
induction back into the lytic lifestyle, phage-encoded
accessory proteins known as excisionases (Xis) or
recombination directionality factors (RDFs) activate
their cognate integrases to mediate the reverse
reaction leading to excision of the prophage.Conservative site-specific recombination
Site-specific recombination reactions result in the
precise integration, excision (or resolution) or inver-
sion of DNA [4]. Despite the different outcomes of
recombination, the site-specific recombinases follow
a generic pathway. Recombinase binds to two
recombination substrates and brings them into
close proximity by protein–protein interactions. The
his is an open access article under the CC BY license
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Fig. 1. Overview of phage integration and excision.
After injection, the phage genome is circularized (blue
circle) and can then integrate via the phage attachment
site (attP; blue arrow) into the bacterial host attachment
site (attB; grey arrow). The integration reaction produces
the prophage flanked by the new attachment sites, attL
and attR, which are hybrids containing half of attP and half
of attB. Excision occurs between attL and attR to
regenerate attP on the excised phage genome and attB
on the host chromosome. Both integration and excision
require integrase, the enzyme that mediates the site-spe-
cific DNA recombination. Excision also requires a pha-
ge-encoded accessory protein, an RDF or a Xis.
2704 Review: New Applications for Integrasessubstrates are then cleaved and the DNA ends are
reorganized in a strand exchange reaction so that
rejoining of the DNA backbone gives rise to the
recombinant products. An important intermediate
during DNA breakage and rejoining is the recombi-
nase covalently linked to the phosphodiester back-
bone. The format ion and removal of the
phosphoseryl or phosphotyrosyl bond is energeti-
cally neutral, and the reactions do not require an
external energy source. This property and the fact
that the DNA rearrangements occur without any net
loss or gain of DNA are features of conservative
site-specific recombination reactions.
There are two evolutionarily distinct families of
site-specific recombinase proteins distinguishable by
sequence homology and mechanism of action. The
families are identified by the eponymous catalytic
residue, that is, tyrosine or serine recombinases. BothTable 1. Summary of tyrosine integrases and their recombina
Phage Bacteria attB (bp) attP (bp) Host factors
λ Escherichia 21 240 IHF and Fis
ICEclc Pseudomonas 18 450 IHFa
L5 Mycobacterium 29 240 mIHF G
P2 Salmonella 17 220 IHF
P22 Salmonella 27 260 IHFc
HP1 Hemophilus 18 420 IHF
a Not confirmed but presumed due to the presence of binding sites
b Directionality controlled via differential integrase expression.
c Not essential for efficient recombination but binding sites present.families of recombinases comprise members that can
mediate integration, excision (resolution) or inversion.
Tyrosine integrases
Integration of the circular phage λ genome into the
Escherichia coli chromosome by a single crossover
was first proposed by Campbell [5]. λ recognizes a
specific attachment site in the bacterial chromosome,
the attB site, and this recombines with a phage
attachment site, attP (Fig. 1 and Table 1). The result is
an integrated prophage flanked by two hybrid sites,
attL and attR, each composed of a half site from attB
and a half site from attP. The integration reaction
between attP and attB is mediated by an integrase,
Int, encoded by phage λ. Int, along with Xis, is also
required for the reverse reaction in which attL and attR
recombine to regenerate attB in the host chromosome
and attP in a circular phage genome that can re-enter
a lytic growth cycle.
λ Int is the founding member of the tyrosine
recombinase family and has been the subject of
intense study [3,6,7]. The recombination mechanisms
used by λ Int and a related recombinase, Cre from
phage P1, are representative of almost all tyrosine
integrases [7]. The recombination substrates for the
tyrosine recombinases generally are composed of
inverted repeats flanking a short 6 to 8 bp non-palin-
dromic sequence or core sequence that is identical
between recombining partners (Fig. 2) [8,9]. Tyrosine
recombinases bind to the inverted repeat sequences
and bring the two sites together in a tetrameric
complex or synapse. The formation of the correct
synaptic complex is necessary for activation of the
recombinases. The catalytic tyrosine residues in two
of the recombinase monomers within the tetramer
attack the DNA backbone to produce a covalent 3′
phosphotyrosine enzyme intermediate and a free 5′
OH terminated DNA strand. The free OH groups from
opposingDNAsubstrates thendisplace the covalently
bound integrases to create a recombinant joint
resembling a Holliday junction (Fig. 2b) [10]. The
steps are repeated for the remaining two recombinase
monomers and DNA strands, in order to resolve the
structure and complete DNA exchange.tion requirements
RDF Length (aa) Molecular mass (kDa) References
Xis 72 9 [108,109]
-b — — [26]
p36/Xis 56 6 [54,110–113]
Cox 91 10 [114–117]
Xis 116 14 [118–121]
Cox 79 9 [122–126]
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Fig. 2. Tyrosine recombinase att site structure and the control of integration versus excision. (a) Overview of Cre/FLP
att site requirements. The recombination sites for Cre (loxP) and FLP (FRT) recombinases are substantially simpler than
the λ model. The minimal recombination requirements are two identical 34 bp sites (each substrate here is colour-coded
either red or black) composed of 13 bp inverted repeats (arrows) flanking an 8 bp asymmetrical core sequence (boxes)
where the crossover occurs [133]. (b) Diagram of the recombination intermediate. During both integration and excision,
tyrosine recombinases catalyse pairwise, sequential cleavage and exchange of single DNA strands from the respective att
sites. This process produces a DNA structure resembling a four-way Holliday junction, which is subsequently resolved to
the recombined products. The green ovals represent λ Int subunits that make up the active tetramer. (c) Overview of the
important features of the λ Int attB and attP attachment sites required for effective recombination. Both sites have left and
right arms (B- and B′-arms, red lines; P-arm, blue line; P′-arm, black line) separated by a central identical sequence of
15 bp, which contains the site of recombination (data not shown). Here, the attL/R sites are annotated using the λ
convention (attL = BP′ and attR = PB′). The attP site is approximately 240 bp in length and, in the integration reaction, λ
Int binds to the arm binding sites (green arrows), and IHF binds to its cognate sites (yellow). In excision, attL has binding
sites for λ Int and IHF and attR has a binding site for λ Int on the P′-arm, which is in a different position and inverted
compared to the site used for Int binding in integration. attR also has binding sites for Fis (purple) and Xis (orange).
2705Review: New Applications for IntegrasesThe distinguishing feature of the phage integrases is
that they are strictly controlled with respect to
integration versus excision. Unlike Cre and its recom-
bination site, loxP, λ Int has four different recombina-
tion substrates: attP, attB, attL and attR (Fig. 2a and c).
Directionality of λ Int recombination is determined by
accessory proteins and their binding sites in the
substrate DNA, in particular, in attP (Fig. 2c). The
attB site for λ Int resembles the simple recombination
substrate described above, that is, an inverted repeat
sequence flanking the core. The attP site is consider-ably larger (~240 bp for λ) and more complex; in
addition to the core complementary sequence, attP
contains a series of overlapping regulatory binding
sites for integrase and accessory proteins (Fig. 2c and
Table 1) [9,11]. The only phage-encoded protein
required for an integration reaction is the integrase.
However, the host-encoded protein integration host
factor (IHF) binds to the attP arms and introduces
sharp bends that are required for the formation of an
integration-competent synaptic complex. Within this
complex is a tetramer of integrase bound to the core
2706 Review: New Applications for IntegrasesDNA sequences, derived from attB and attP. Two
sequential DNA cleavage and strand exchange steps
occur to generate attL and attR. Crucially for the
maintenance of a stable prophage state, the attL
and attR sites are not substrates for the integrase
and IHF alone. In order for the prophage to be
excised, integrase, IHF and additional accessory
proteins are required, a phage-encoded excisio-
nase (Xis) and host-encoded Fis [12,13]. Together,
IHF, Xis, Fis and integrase bind to the P-arm in attR
inducing a compact loop structure that reconstitutes
a tetrameric integrase complex bound to the core
sequences that resembles the complex present
during integration, but with a modified configuration
of the core DNA sequences (Table 1) [10,14].
Sequential DNA cleavage and strand exchange
reactions within this excision-competent complex
yields attP and attB once more.Applications of Tyrosine Integrases
Chromosome integration and cloning tools
Integrase-mediated chromosomal integration
systems for transgenes were first described in the
early 1990s for E. coli [15], Staphylococcus aureus
[16] and Actinobacteria [17–19]. These techniques
relied on the use of either a single suicide plasmid
encoding a selectable marker gene, int and attP or a
two-plasmid system in which an attP is carried on a
suicide plasmid and is introduced into target cells
that already contain a separate integrase expres-
sion plasmid. Site-specific integration occurs via the
endogenous attB site and can be easily selected for
after conjugation or transformation. The integrated
plasmids are very stable so long as the xis gene,
often located adjacent to the phage int gene, is not
included in the integrating vector [17]. This approach
was soon proposed for the production of recombinant
vaccines using the Bacillus Calmette–Guérin strain
widely applied as a live attenuated vaccine against
Mycobacterium tuberculosis [20]. An integrating
plasmid based on mycobacteriophage L5 integrase
was constructed with an expression cassette consist-
ing of the promoter region and the first six codons of
the major heat shock protein Hsp60 followed by a
multiple cloning site. Genes encoding antigens of
interest could then be introduced as fusion proteins to
be expressed in vivo post-vaccination.
These methods were fine-tuned in Pseudomonas
where integrating vectors that exploited the ΦCTX
recombinase were created. In addition to integrase,
the plasmids contained the ΦCTX attP site, a
tetracycline resistance gene and a multiple cloning
site [21,22]. Conjugation into Pseudomonas aeru-
ginosa produced efficient integration into the native
chromosomal attB site (frequencies of 10−8 to 10−7)[21]. FRT sites flank the multiple cloning site and
facilitate the removal of the entire plasmid backbone
upon expression of Flp recombinase, rendering the
final recombinant strain markerless an essential
feature for any environmental or medicinal applica-
tions. Similar single-copy integration vectors have
since been constructed for use in other organisms,
such as Francisella tularensis [23]. An interesting
adjunct to this is the recent description of a so-called
“Clonetegration” technique, which combines cloning
and site-specific integration into a single step to
accurately deliver DNA of interest into a native attB
site [24]. The requisite pOSIP plasmid contains two
multiple cloning sites that flank a pUC origin of
replication for plasmid propagation and the counter-
selection marker ccdB, both of which are replaced
during the initial cloning step by the desired insert
using standard techniques, for example, ligation or
Gibson assembly. The reaction mix is then directly
transformed into the target cells. As pOSIP also
contains an antibiotic resistance gene, an attP site
and a cognate temperature-inducible integrase
gene (induced immediately after the DNA is intro-
duced by transformation), integration into a com-
patible chromosomal attB site occurs. The integrase
and antibiotic resistance genes are flanked by FRT
sites and thus can be removed by expression of Flp
recombinase if required. The efficiency of this
procedure was tested for five tyrosine integrases
endogenous to E. coli (ϕ80, λ, HK022, P21 and 186)
plus one heterologous serine integrase (ϕC31).
Multiple orthologous integrases can also be used to
mediate simultaneous or sequential integration of
different plasmids into their respective attB sites. It is
important to note thatmost of these integration vectors
rely on the presence of endogenous attB sites and
host-encoded factors; therefore, it is a common
practice to source the integrase fromaphage infecting
the bacterial strain intended for genetic manipulation.
Whilst convenient, the disadvantage of relying on the
endogenous attB sites is the lack of control on where
the attB site is located. One of the recombination
systems developed in Clonetegration is the heterolo-
gous ϕC31 phage integration system, a serine
integrase described below. The ϕC31 attB site was
inserted at a pre-defined site in the chromosome, thus
expanding the integration strategies available to the
researcher [24,25].
A key goal for synthetic biology is to be able to
mobilise large (megabase pairs down to 100 s of
kilobase pairs) fragments of DNA for use in diverse
target organisms, many of which may not be
amenable to standard molecular genetic techniques.
Integrases can provide a means of efficient integra-
tion of large DNA fragments into specific genomic
locations. For example, the intB13 λ-like integrase of
an integrating conjugative element (ICEclc) found in
Pseudomonas knackmussii has recently been
shown to catalyse the targeted integration of large
2707Review: New Applications for Integrasescosmid and BAC substrates (up to 75 kb) into the
genome of the relatedPseudomonas putida species
[26,27]. Expression of the integrase in E. coli
resulted in severe growth inhibition; therefore,
integration vectors were constructed with a hybrid
promoter containing lacO sites to tightly repress
integrase expression in lacI+ hosts [24,25]. After
conjugation into the target Pseudomonas species,
which does not possess lacI, repression is alleviated
and efficient integration can occur [26]. In addition,
the integration cassette was also incorporated into a
tnpA mini-transposon that can be mobilised into
pre-existing vectors to rapidly produce integrating
plasmids without the need for de novo construction.Gateway™
The most widely used tyrosine integrase recom-
bination system is the Gateway™ cloning method
(Life Technologies Ltd, California). Gateway™ is
based on an in vitro application of λ integrase to
facilitate rapid cloning of linear DNA into an “entry
vector” and subsequent exchange into specialised
plasmids for downstream use [28–30]. Essentially,
the system exploits the ability of the integrase to
accurately and efficiently rearrange DNA that is
flanked by compatible att sites; the identity of these
att sites (attP/B/L/R) relative to the insert allows the
transfer of target DNA to be precisely manipulated.
For example, an insert flanked by two attB sites will
be swapped with another insert flanked by two attP
sites when incubated with purified integrase and
IHF. Supplementation with excisionase protein will
catalyse the reverse reaction to restore the original
substrates. Use of a recombinase in this manner
removes the problems associated with traditional
cloning, for example, reliance on the presence and
compatibility of restriction sites, time-consuming
reactions andmultiple purification steps. This simple
application has appeared in hundreds of publica-
tions, demonstrating the huge potential for optimi-
zation and commercialisation of recombinase
technology.
Although useful for relatively straightforward
cloning or DNA mobilization applications, there are
several major drawbacks of phage-encoded tyro-
sine integrases. First is a requirement for
host-encoded accessory proteins to bend the attP
substrate to favour efficient integration or excision
reactions. Consequently, the attP site is long and
complex to accommodate multiple integrase and
accessory protein binding sites (Table 1). There are
rare instances where host accessory proteins are
non-essential for tyrosine integrase activity but
merely act as subtle enhancers; however, the
minimal attP sites for these enzymes are still
comparable in size to other family members
[31,32]. Certain mutant integrases that overcomesome, but not all, of these limitations have been
developed, but these suffer from severely attenuat-
ed efficiency (for review, see Groth and Calos [33]).
Furthermore, tyrosine integrases have a strong
preference for a supercoiled attP site for integration
and attL and attR for excision. The major drawbacks
of the tyrosine integrases for complex DNA assem-
bly are therefore the large scar sequences (attP, attL
and attR) and the need for host proteins that limit the
potential for cross-species or cross-genera use.
Serine integrases
Serine integrases possess a number of properties
that overcome some key impediments to synthetic
biology offered by their tyrosine integrase counter-
parts. Perhaps most important is the ability to
catalyse recombination between relatively simple
attachment sites with no impairment of directionality
control [34,35]. Both the attB and attP sites are
typically ≤50 bp with different inverted repeat
sequences flanking 2 to 12 bp of complementary
sequence, which includes the recombination cross-
over point (Table 2 and Fig. 3a) [36,37]. Serine
integrases bind to their target attachment sites as
dimers. An exciting recent development is a
structural model of a serine integrase bound to its
cognate attP half site revealing for the first time how
integrase recognizes its substrates [38,39]. Interac-
tions between the integrase dimers bound to attP
and attB or attL and attR form tetramers that bring
the recombination crossover sites into close prox-
imity to form the synaptic complex (Fig. 3b) [35,40–
42]. Within this complex, integrase is activated and
the catalytic serine residues break all four DNA
strands simultaneously [35,41,42]. These double-
strand breaks are staggered with 2-nucleotide 3′
overhangs and the concomitant formation of a
phosphoseryl covalent bond between each integrase
monomer and the four recessed 5′ ends [7,41,42].
Each cleaved end remains covalently bound to an
integrase monomer as two integrase subunits rotate
180° relative to the other two subunits in a process
known as subunit rotation [43–46]. This process
effectively swaps two half sites such that ligation of
the cleaved ends yields recombinant products
(Fig. 3b) [40,46–48]. The complementarity of these
core bases in compatible att sites is essential for
recombination to proceed to completion [40,46,47].
Only when the core bases are the same in the two
parent attachment sites can the DNA backbone of the
recombinants be joined and this feature is useful for
dictating which ends can join to which in a DNA
assembly strategy (see below and Fig. 4). It should
also be noted that there is no topological restraint on
the position of the attachment sites; although attB and
attP are normally located on different DNA molecules
in which the outcome is integration, if they are
positioned on the same molecule either in the
Table 2. Summary of serine integrases and their recombination requirements
Phage Bacteria attB (bp) attP (bp) RDF Length (aa) Molecular mass (kDa) References
ϕC31 Streptomyces 34 39 gp3 244 27 [36,52]
ϕBT1 Streptomyces 36 48 gp3 247 28 [50,52]
TG1 Streptomyces 39 43 gp25 240 27 [127]
Bxb1 Mycobacterium 38 48 gp47 255 28 [40,51]
R4 Streptomyces 64 50 -a — — [128]
ϕMR11 Staphylococcus 34 34 -a — — [129]
ϕRv1 Mycobacterium 40 52 Rv1584c/Xis 73 8 [130]
TP901-1 Lactococcus 31 50 ORF7 64 8 [49,131]
A118 Listeria 42 50 -a — — [132]
a Unknown at present.
2708 Review: New Applications for Integraseshead-to-head orientation or in the head-to-tail orien-
tation, integrase will mediate inversion and deletion
respectively.
In phage integration reactions that depend on
serine integrases, the only protein required to
mediate attP × attB recombination is the integrase
itself, unlike tyrosine integrases that require an
accessory host protein (IHF) for integration. Most
serine integrases are inert on attL and attR, although
traces of the excision reaction have been observed
in some systems [49,50]. This controlled direction-
ality allows integrating plasmids, such as those
described above based on the tyrosine integrases,
to be extremely stable in the chromosome. For
efficient excision to occur, the serine integrases
require a phage-encoded RDF. RDFs that work in
conjunction with serine integrases have been
discovered in several phage recombination systems
(Table 1), although only two have been described in
any detail biochemically: Bxb1 gp47 and ϕC31 gp3
[51,52]. The RDFs control the directionality of
recombination in two ways; first, by enabling
synapsis between attL and attR sites and thus
activating excision, and second, by inhibiting syn-
apsis between attB and attP sites, reducing inte-
gration [52]. gp3 and gp47 act by protein–protein
interactions with their cognate Int [51,52]. ϕC31 gp3
is able to bind directly to Int both in solution and
when Int is complexed with DNA and seems to
impart a conformational change in integrase that
favours excision [52]. It is worth noting that despite
the lack of characterized RDFs, ϕC31 gp3 is closely
related to those encoded by the Streptomyces
phages ϕBT1 and TG1, and there are numerous
mycobacteriophages with RDFs related to Bxb1
gp47 [52,53]. The RDFs related to gp3 and those
related to gp47 appear to have evolved indepen-
dently to act as RDFs using similar mechanisms,
presumably through convergent evolution [52].
In practice, the minimalist requirements of serine
integrases for att sites and accessory proteins mean
that in vitro and in vivo strategies for DNA assembly
and other applications are far easier to design and
optimize. This point is particularly salient when thesystem is applied to heterologous organisms that
may share very little in common with the native host.
Furthermore, serine integrases do not require any of
the substrates to be supercoiled so that linear
fragments can be recombined efficiently in vitro in
both integration and excision reactions.Applications of Serine Integrases
in DNA Integration and
Genome Engineering
The original application of ϕC31 integrase was in
the development of integration vectors for use in
Streptomyces, which is the natural host for ϕC31
and therefore contains an innate attB site for
integration [55,56]. These efficient and stable
integrating plasmids rapidly became the vectors of
choice for introducing DNA into the streptomycetes
and related bacteria and can be used for precise
ablation of target sequences [57] or even for the
transfer of whole antibiotic biosynthesis clusters into
heterologous hosts (for reviews, see Refs. [58] and
[59]). Serine-integrase-based integration vectors,
like those based on the tyrosine integrases, can also
be multiplexed within a single organism without any
interference between them [60].
Heterologous hosts
The use of serine integrases in heterologous hosts
took hold very quickly after their biochemical proper-
ties were first described [61]. The idea of importing
site-specific recombination systems into higher eu-
karyotes to create rational, precise genome rear-
rangements was first developed with the phage P1
“Cre/loxP” and the yeast “Flp/FRT” systems, both of
which use tyrosine recombinases [62,63]. Both Cre/
loxP and Flp/FRT regenerate the original substrates
after recombination. Consequently, both systems are
efficient at creating deletion mutants by excising DNA
located betweendirectly repeated recombination sites
but their reversibility is problematic for stable DNA
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Fig. 3. Breakage and rejoining of the attachment sites
by serine integrases. (a) Organization of the attachment
sites used by the serine integrases. The attachment sites
are less than 50 bp in length and attP (blue) and attB (grey)
are inverted repeats. The thick blue and grey lines
represent the two strands of DNA with the central
dinucleotides shown, in this case, two T:A base pairs.
The black lines represent the position of the staggered
breaks made when integrase cuts all four strands of the
two substrates concertedly. Exchange of the half sites
represents the integration reaction (down-pointing arrow)
and the excision reaction (up-pointing arrow). The bases in
the staggered ends base pair in the recombinant arrange-
ment and integrase can then rejoin the phosphodiester
backbone to generate the products. (b) The DNA half sites
are exchanged by subunit rotation. Within the active
tetramer of integrase subunits, one pair of subunits, still
bound to the half sites from opposing substrates, rotate
180° compared to the other pair of subunits. This action
brings together the DNA ends originating from different
substrates, which can then be joined to form products.
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Fig. 4. Use of serine integrases for DNA assembly.
Attachment sites will only recombine if their dinucleotides
involved in the staggered break can base pair in the
recombinants (Fig. 3). It is therefore possible to match attP
and attB sites together with identity of the two nucleotide
bases at the crossover site. (a) Six possible dinucleotides
at the centre of the attachment sites for use with ϕC31
integrase have been colour-coded. Thus, only attP and
attB with the code navy blue will recombine, only those
with the code green will recombine and so on (note that
attP or attB sites do not recombine with themselves).
(b) Use of the dinucleotide specificity to assembly DNA in a
predictable and ordered way. The five DNA fragments
shown here encoding five different fragments encoding
either single or multiple genes from a metabolic pathway
can be recombined together using a single integrase in an
in vitro recombination reaction. Addition of the sixth
fragment containing the vector allows the assembly to be
amplified in E. coli. Adapted from Colloms et al. [101] with
permission.
2709Review: New Applications for Integrasesintegration. This problem can be mitigated by
recombination site mutations in either of the inverted
repeats or the central spacer region (Fig. 2a) that
facilitate “Recombinase Mediated Cassette Ex-
change”, or RMCE (for review, see Turan et al.
[64]). For example, in the Cre/loxP system, even
single nucleotide changes within the loxP spacer
region can lead to incompatibility with the WT
(wild-type) site whilst retaining compatibility withan identical mutant site [65,66]. By flanking target
and donor DNA with heterologous loxP sites (e.g.,
loxPmut-target-loxP and loxPmut-donor-loxP), cassette
exchange is promoted and unwanted deletion events
precluded [66]. The reaction is not obligately unidi-
rectional but can be forced close to completion by a
molar excess of the donor [64]. Meanwhile, sites
containing certain mutations in either of the left or right
inverted repeat sequences are functional alone but
double mutants are inactive [67]. These properties
have been used independently or in conjunction with
the spacer mutants to bias recombination towards
integration [66]. Briefly, if the left inverted repeat is
mutated in one loxP site and the right is mutated on its
partner site, recombination will produce aWT site and
an inactive double mutant, thus inhibiting further
recombination.
The major advantage of the serine integrases is
that they can catalyse highly efficient irreversible
recombination using simple att sites and, for this
reason, can also be used for applications that require
2710 Review: New Applications for Integrasesefficient DNA integration in addition to cassette
exchange. Simple modifications have been used to
increase serine integrase activity in heterologous
systems, for example, the introduction of a nuclear
localization signal [68], codon optimization [69],
fusion of the integrase ORF (open reading frame) to
an endogenous 3′ untranslated region to favour in
vivo expression in zebrafish [70] and addition of a 3′
polyadenylate cap to increase mRNA stability in a
number of insect model organisms [71–73]. A
concept that has rapidly taken root is that ϕC31
integrase can be an important tool for gene therapy,
specifically the introduction of corrected genes into a
mammalian chromosome through integration into
endogenous sites that resemble attachment sites,
termed pseudo-attP sites [74]. Integration into
pseudo-attP sites has been used in several medic-
inally relevant studies, for example, production of
therapeutic levels of human factors VIII and IX in
mice [75,76], gene therapy of skin disorders by
functional complementation of human progenitor
cells or primary keratinocytes [77,78], creation of
transgenic cattle that express milk laced with the
human β-defensin-3 antimicrobial peptide [79] and
expression of transcription factors to generate
induced pluripotent stem cells from mouse embry-
onic fibroblasts and human amniotic cells [80].
Mapping of 196 pseudo-attP integrations in three
human cells lines detected 101 pseudo-attP sites
that could be used by ϕC31 integrase [81]. Despite
these observations, there are problems associated
with reliance on pseudo-attP sites for site-specific
integrations. First, integrations into the pseudo-attP
sites are often non-reciprocal; that is, small dele-
tions were a frequent occurrence in the flanking
DNA [81,82], although small deletions can also
occur in mammalian cell lines even when integrases
are provided with two cognate attachment sites [83].
Second, it is debatable whether integrase genuinely
recognizes the pseudo-attP sites or whether these
events are simply “ectopic” or random integrations.
Either way, the frequency of use of pseudo-attP
sites is very low as integrase can be expressed
constitutively in the presence of one of its attach-
ment sites over many cell duplications without any
observable gene rearrangements occurring at the
cognate attachment site [82,84,85].
In order to make use of the high efficiency of
site-specific recombinases, a docking or landing site
containing an attachment site is normally introduced
into the chromosome of a cell line or animal that will
recombine with the partner attachment site in the
presence of integrase. The docking site/landing pad
is inserted either randomly into the target genome
using established methods of transgenesis or by
homologous recombination, as demonstrated in
mouse embryonic stem cells or in the chicken
DT40 cell line [74,83,84,86]. Transgenes can then
be integrated efficiently into the docking site viasite-specific recombination. Besides increased effi-
ciency of recombination, there is also the additional
advantage that a specific docking site can be
identified that supports reproducibly high levels of
gene expression and a low likelihood of gene
silencing. For example, in mouse embryonic stem
cells, a reliable position for the integration of
transgenes is the ROSA26 locus [87,88]. A docking
site for ϕC31 integrase was introduced into the
ROSA26 locus in a mouse line to create an attP
knock-in. Pronuclear injection of plasmid DNA into
zygotes for this mouse line yielded 40% of pups with
the desired DNA located in the docking site [86].
This is a highly efficient and reproducible way of
generating transgenic mice and the line is marketed
under the trade name TARGATT™ (Applied Stem-
Cell, Inc).
Docking sites have also been successfully
introduced into insects, including Drosophila [89]
and Anopheles [90] species. The use of docking
sites in Drosophila has had a substantial enabling
effect on genetic research in this model organism
as the introduction of different alleles at a single
position permits greater consistency between
constructs and largely avoids transgene position
effects [91]. Significantly, the list of organisms in
which ϕC31 integrase has been used for genome
engineering continues to grow. In addition to the
uses in mammalian cell lines and insects detailed
above, serine integrases are now being applied in
zebrafish [70,86,92] and silkworm embryos [73,93]
and, for marker deletion, in a variety of plant
species including Arabidopsis, barley and wheat
[94–96].
Use of multiple site-specific recombinases has
become possible since the advent of ϕC31 integra-
se-mediated genome engineering. An iterative
assembly method has been developed in mamma-
lian cells whereby successive rounds of plasmid
integration using Cre recombinase are followed by
removal of the selection marker and loxP site by a
serine integrase from either ϕC31 or ϕBT1 [84,85].
As illustration, this iterative technique was used to
produce a 400 kb transgene array in a human
artificial mini-chromosome in the Chinese hamster
cell line [85]. There is no theoretical limit to the
number of rounds that could be carried out and
entire genomes could be systematically constructed
by this method. Monetti et al. use a combination of
recombinases to increase the range of genome
engineering approaches in mice [97]. Their technol-
ogy is to replace a critical part of a gene with a ϕC31
attP docking site creating both a null mutant and the
opportunity to reinsert different alleles. The tech-
nique uses Flp/FRT to remove unwanted vector and
marker sequences and leaves the researcher the
option of using the Cre/loxP system elsewhere in the
genome. This approach has been adopted by the
North American Conditional Mouse Mutagenesis
2711Review: New Applications for IntegrasesProject†, and to date, they have created null alleles
in more than 600 genes.Use of Serine Integrases in Synthetic
Biology: Metabolic Pathway Assembly
Microbes have long been used to manufacture
useful transgenic compounds, a successful example
of which is artificial human insulin production by
E. coli [98]. However, the traditional technology of
plasmid expression vectors created using restriction
enzymes or homologous recombination is only
suitable for relatively simple products requiring a
couple of genes for synthesis. More complex
applications require more sophisticated methods
for the construction, mobilisation and optimization of
large multi-component synthetic operons [99]. Site-
specific recombinases are capable of filling this
niche.
The integrase isolated from the Streptomyces
phage ϕBT1 has been used to assemble in vitro
DNA fragments encoding the genes required for
large and complex secondary metabolic pathways.
The use of the integrase-mediated DNA assembly
modularizes the pathway such that parts can be
easily changed without having to reclone the entire
pathway from the beginning [50,100]. The system
exploits the requirement for a complementary
central dinucleotide pairing between attB and attP
sites in order for recombination to occur, therefore
allowing six orthologous target sites. Using this
system an ~62 kb epothilone synthesis cluster was
constructed, including the large epoD gene
(~22 kb), in two construction steps. At least seven
fragments could be stitched together in a single in
vitro reaction.
Independently, using a similar strategy to that of
Zhang et al. but based on ϕC31 integrase (Fig. 4)
[100], directional assembly of up to five components
flanked by orthogonal asymmetric attB/attP sites into
a plasmid vector was achieved at high efficiencies
[101]. The efficiency and fidelity of even the
five-gene assembly was easily sufficient to make
downstream applications practical; 18% of N105
colonies/reaction contained the desired construct. In
the recombined product, each component is abutted
by attL sites, which, when provided with RDF, can
recombine with attR sites to integrate up to a further
five modules or simply to provide flexible removal
and replacement opportunities. The utility of this
system was demonstrated by the successful inte-
gration of an operational, artificial carotenoid bio-
synthesis operon in E. coli. Various enhancements
could then be tested by varying gene order, RBS
optimization and supplementary gene provisions.
Clearly, these new tools could have a major impact
on industrial production of biological products, for
example, modification of amenable hosts withsynthetic operons for conversion of biomass to
biofuel or production of novel antibiotics.Memory and Counting Devices
Another intriguing application for serine recombi-
nases is to form an integral component of a binary
biological processor. The use of recombinases for
the creation of biological computers that count and
record stimuli has been described using invertases
(Hin or FimB) or non-directional tyrosine recombi-
nases (Cre and Flp) [102–104]. The ability to control
the direction of serine integrases however expands
the capability of biocomputers using this general
approach. Discrete inducible expression of an
integrase gene and its cognate RDF can affect fully
reversible changes in expression profiles in re-
sponse to alternative input stimuli [105]. Essentially,
this is achieved by flanking a promoter with attB and
attP sites that mediate inversion of the promoter and
hence expression of two alternative transcription
units. Furthermore, these changes are vertically
heritable and, in the absence of a reset signal,
stable for over 100 generations and receptive to
additional inputs for over 90 generations. In a similar
fashion, the level of complexity can be scaled up by
using two pairs of integrases/excisionases and
inversion cassettes encoding either promoter ele-
ments or asymmetric transcription terminators. This
additional “computational” capacity enables the full
range of Boolean logic gates to be programmed to
respond to different combinations of independent
stimuli (Fig. 5) [106,107]. These capabilities raise the
possibility of organisms able to not only sense their
environment but also record information and re-
spond accordingly in a predetermined manner.
Potential applications could include environmental
biosensing of pollutants or clinical diagnostic tests.
Furthermore, it is easy to imagine up-scaling the
system with additional integrases to allow more input
signals to be detected or the use of orthogonal
crossover sites for individual integrases (see above)
to allow multiple outputs to be instigated in response
to each input.
General comments and future prospects
Phage integrases are tools for generating precise
DNA rearrangements in vivo and in vitro. For many
organisms or cell lines, the level of homologous
recombination is extremely low and is not a viable
route to generating desired genetic constructs. In
these situations, the greater efficiency of site-spe-
cific recombination is an extremely useful substitute
as demonstrated by the many researchers who have
deployed integrases for use in higher eukaryotes.
Although some integrases, notably ϕC31 and Bxb1
integrases, appear to be “plug and play” and display
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OR
T XOR
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Fig. 5. Using integrases to construct Boolean logic
gates in E. coli. Extracellular signals [1,2] activate the
synthesis of two different integrases (Int1 and Int2) that
have different cognate and non-cross-reacting recombi-
nation sites (shown as either pink or black block arrows). If
the recombination sites are oriented head to head,
inversion occurs (AND, NAND, NOR, XOR and XNOR
gates), but if they are head to tail, deletion occurs (OR
gate). Between the recombination sites is either a
unidirectional transcription terminator (red T in oval when
active; grey inverted T when inactive) or a promoter (black
arrow inside the green oval). The green arrow represents a
reporter gene such as EGFP. Adapted from Bonnet et al.
[106] with permission. †http://www.norcomm.org/index.htm
2712 Review: New Applications for Integraseshigh levels of portability from one organism to
another, others are only active in bacteria [82].
Furthermore, some serine integrases, although
active and yielding the desired DNA rearrange-
ments in eukaryotic cells, can cause small deletions
in the products, attL or attR [81–83]. The eukaryotic
cell environment therefore still presents a challenge
for conservative site-specific recombination.
The most exciting and promising applications of
phage integrases, particularly serine integrases, lie
in the field of synthetic biology. These have been
exemplified by their uses in metabolic pathway
assembly and in the construction of digital counters
and logic gates. What is needed in this field are
more integrases that act orthogonally and can be
multiplexed for greater versatility and increased
efficiency. The use of integrases for modularising
and assembling complex pathways will greatly
facilitate optimization of metabolite production and
allow these pathways to be easily transferred into
different hosts. Moreover, the use of RDFs to retrofit
metabolic pathways should also streamline the
modification of previously constructed pathways.
Serine integrases complement other ingenious
DNA assembly methods currently available, in
particular, the seamless DNA assembly methods
such as Gibson assembly, SLICE and overlap
extension polymerase chain reaction. It used to be
the case that cloning a single gene would take at
best a couple of weeks.We now hope that we can usethat time more effectively in designing and recon-
structing whole metabolic pathways and even whole
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